SCHEMBL6358162

SCHEMBL6358162

CC(C)(C)OC(=O)C(C)(C)Sc1cccc(CCN2C(=O)c3ccccc3C2=O)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 2/20 0.42
RAB9A P51151 5/20 0.41
ALDH1A1 P00352 5/20 0.41
KMT2A Q03164 5/20 0.41
NPC1 O15118 3/20 0.41
MAPT P10636 2/20 0.41
MEN1 O00255 2/20 0.41
POLB P06746 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
KDM4E B2RXH2 2/20 0.41
GAA P10253 1/20 0.41
HSD17B10 Q99714 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
LMNA P02545 2/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3885465 0.88 CASP3 (0.45) CASP3RAB9AALDH1A1KMT2ANPC1
SCHEMBL4576126 0.80 PPARA (0.47) CASP3RAB9AALDH1A1KMT2ANPC1
SCHEMBL6361178 0.79 HTR6 (0.46) TAAR1
SCHEMBL29451629 0.78 SLC7A5 (0.50) CASP3RAB9AALDH1A1KMT2ANPC1
SCHEMBL4842190 0.77 RAB9A (0.52) CASP3RAB9AALDH1A1KMT2ANPC1
SCHEMBL2434908 0.75 PPARA (0.50) RAB9AALDH1A1KMT2AMAPTMEN1
SCHEMBL4840291 0.75 RAB9A (0.50) CASP3RAB9AALDH1A1KMT2AMAPT
SCHEMBL6359890 0.74 NR1H3 (0.33) RAB9AALDH1A1KMT2ANPC1MAPT
SCHEMBL2414714 0.74 PKM (0.54) RAB9AALDH1A1KMT2ANPC1MAPT
SCHEMBL5801697 0.73 CASP3 (0.52) CASP3RAB9AALDH1A1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050075377-A1 PPAR compounds PFIZER INC 2005-04-07 US disclosed
EP-1372632-A1 PROLIFERATIVE ACTIVATOR RECEPTOR (PPAR) COMPOUNDS Pfizer Products Inc. (US) 2004-01-02 EP disclosed
US-20020169192-A1 PPAR compounds HAYWARD CHERYL M (US) 2002-11-14 US disclosed
WO-2002064130-A1 PROLIFERATIVE ACTIVATOR RECEPTOR (PPAR) COMPOUNDS PFIZER PRODUCTS INC. (US) 2002-08-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020169192-A1 PPAR compounds PPARA, PPARG, PPARD CASP3 2032/4885RAB9A 3479/4885ALDH1A1 1922/4885
US-20050075377-A1 PPAR compounds PPARA, PPARG, PPARD CASP3 2032/4885RAB9A 3479/4885ALDH1A1 1922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.